tirzepatide 17.5mg Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Tirzepatide Dosage Chart for Weight

Think About How Fast You Want to Start If timing matters to you, ask how long the process typically takes from sign up to your first shipment

If you see markings up to 40 with a red cap, you have a U-40 syringe, which requires different calculations

Symptoms include high fever, irregular heartbeat, agitation, dizziness, tremor, seizures and unconsciousness

Starting in July 2026, eligible Medicare beneficiaries will gain access to certain weight-loss medications for $50 a month through a temporary initiative called the Medicare GLP-1 Bridge program

503B outsourcing facility compounding of tirzepatide ended in early 2025